Profile of:

Martin Rudwaleit

Rheumatologist at Klinikum Bielefeld, Germany, since 2014. Prior services as a rheumatologist at Charité, Berlin, Germany, 1989-2010, Rheumatologist at Ev. Krankenhaus Hagen-Haspe 2010-2011, Rheuamtologist in Berlin, 2011-2014 ASAS EC member and ASAS secretary from 2010-2016

Full name: Martin Rudwaleit

Current country: Germany

Membership level: Full

Type of membership: Advisory Board

Number of publications: 10

Radiographic sacroiliitis progression in axial spondyloarthritis: central reading of 5-year follow-up data from the ASAS cohort (2021)

Data-Driven Definitions for Active and Structural MRI Lesions in the Sacroiliac Joint in Spondyloarthritis and their Predictive Utility (2021)

Assessment of radiographic sacroiliitis in anteroposterior lumbar vs conventional pelvic radiographs in axial spondyloarthritis (2021)

Relation of α 2-Antiplasmin Genotype and Genetic Determinants of Fibrinogen Synthesis and Fibrin Clot Formation with Vascular Endothelial Growth Factor Level in Axial Spondyloarthritis (2020)

The impact of certolizumab pegol treatment on the incidence of anterior uveitis flares in patients with axial spondyloarthritis: 48-week interim results from C-VIEW (2020)

IgA antibodies against CD74 are associated with structural damage in the axial skeleton in patients with axial spondyloarthritis (2020)

Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis (2020)

MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group (2019)

Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts (2019)

Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison (2019)